NanoFEN and chemotherapy treatment significantly inhibited tumor progression in lung squamous carcinoma xenografts, lung adenocarcinoma xenografts (Fig. 3a, b left) and CRC xenografts, the latter with or without mutated KRAS (Fig. 3c, d left). Here, KRAS is linked to neoplasm.